This article has been updated to clarify that the funds Progenity plans to use to meet settlement obligations has already been accrued.
NEW YORK — Molecular diagnostics testing lab Progenity on Wednesday filed to sell up to $100 million of its shares through an initial public offering on the Nasdaq.